ロード中...
Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits
BACKGROUND: Carvedilol (CVD) is used for the treatment of essential hypertension, heart failure, and systolic dysfunction after myocardial infarction. Due to its lower aqueous solubility and extensive first-pass metabolism, the absolute bioavailability of CVD does not exceed 30%. To overcome these d...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357615/ https://ncbi.nlm.nih.gov/pubmed/25834396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S80294 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|